GMB Korea Largest Shareholder Group Raises Stake to 58.73% From 58.70%
Bitget2026/10/30 04:20- GMB Korea's largest shareholder group raised its stake to 58.73% from 58.7%, according to an October 30, 2026 disclosure.
- Executive Choi Wan-uk purchased 5,000 common shares on October 29, increasing his holdings to 65,000 shares.
- The group's total holdings rose to 11,201,313 common shares from 11,196,313.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The US FDA requires semaglutide, tirzepatide, and other GLP-1 drugs to include new warnings about the risk of eye disease.
NAION is an eye disease that can cause sudden, painless loss of vision, with some patients potentially experiencing permanent visual impairment. The drugs involved include products from Eli Lilly and Novo Nordisk. According to analysts at Citi, the incidence of NAION is relatively low, and given the significant benefits of GLP-1 drugs in weight control and blood sugar management, the actual impact on prescription behavior is expected to be limited. On Monday, the stock prices of Eli Lilly and Novo Nordisk increased, with the news not causing any significant impact on their share prices.
CleanSpark presents fully funded Sandersville project in investor presentation
Forge Nano completes acquisition of HzO
Crypto prices
More
